I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 22% ± 6% | |
| plasmacytoid dendritic cell | 7 studies | 22% ± 6% | |
| goblet cell | 5 studies | 31% ± 18% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 21% ± 5% | |
| classical monocyte | 4 studies | 20% ± 3% | |
| mucosal invariant T cell | 4 studies | 19% ± 2% | |
| epithelial cell | 4 studies | 33% ± 11% | |
| astrocyte | 4 studies | 27% ± 8% | |
| oligodendrocyte | 4 studies | 22% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
| non-classical monocyte | 3 studies | 20% ± 5% | |
| plasmablast | 3 studies | 36% ± 16% | |
| microglial cell | 3 studies | 22% ± 4% | |
| hepatocyte | 3 studies | 40% ± 18% | |
| GABAergic neuron | 3 studies | 42% ± 3% | |
| glutamatergic neuron | 3 studies | 53% ± 7% | |
| oligodendrocyte precursor cell | 3 studies | 28% ± 6% | |
| natural killer cell | 3 studies | 21% ± 2% | |
| pancreatic A cell | 3 studies | 18% ± 1% | |
| fibroblast | 3 studies | 18% ± 2% | |
| macrophage | 3 studies | 22% ± 3% | |
| basal cell | 3 studies | 27% ± 13% | |
| gamma-delta T cell | 3 studies | 16% ± 1% |
